Article
Unravelling modifiers of breast and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: update on genetic modifiers.
Journal of internal medicine - 1 Apr 2012
Barnes D R, Antoniou A C
Abstract excerpt
Pathogenic mutations in the tumour suppressor genes BRCA1 and BRCA2 confer increased risks for breast and ovarian cancer and account for approximately 15% of the excess familial risk of breast cancer amongst first-degree relatives of patients with breast cancer. There is considerable evidence indicating that these risks vary by other genetic and environmental factors clustering in families. In the past few years,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
